FDA clears Welch Allyn Protocol's wireless patient monitor:
This article was originally published in Clinica
Welch Allyn Protocol has received US FDA 510(k) clearance to market its Micropaq wireless ambulatory patient monitor. The device, developed principally for cardiac care, monitors ECG, heart rate and pulse oximetry. It is compact and wearable, weighing under a pound. The product can be connected wirelessly to the Beaverton, Oregon company's Acuity central workstation and its FlexNet network, which provide vital signs data and patient information between any locations via secure internet access. The device can also be used in applications outside cardiac care because it provides an LCD of vital sign data and can operate outside of the wireless network.
You may also be interested in...
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.